Health Care: Drugs

Acorda Therapeutics Inc (ACOR: NASDAQ)

$31.77 -0.2 | -0.63%
09/01/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 31.97
52 Week High 45.45
52 Week Low 27.92
Avg. Daily Vol. (Mil) 0.62
Beta (3 year) 1.00
Share Related Items
Mkt Cap (Mil) 1,369.80
Shares Out (Mil) 42.85
Float (Mil) 31.08
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.00
Current Ratio 3.80
LT Debt/ Equity 0.52
Total Debt / Equity 0.52
Valuation Ratios
Price Earnings 134.50
Price/Sales 3.13
Price/Book 2.44
Price/Cash Flow 39.80
Per Share Data
Earnings 0.24
Sales 10.21
Book Value 13.08
Cash Flow 0.80
Business Summary
Acorda Therapeutics Inc is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of neurological disorders.
General Information
420 Saw Mill River Road
Ardsley, NY 10502
www.acorda.com
Industry : Drugs
Sector: Health Care
Employees: 489
CEO: Ron Cohen,M.D.
Short Interest
Current Month (Mil) 6.29
Previous Month (Mil) 6.40
Short Interest Ratio (Days) 15.70
Management Effectiveness
Return on Equity 1.80
Return on Assets 0.90
Return on Investments 1.20
Profitability
Gross Margin 85.60
EBIT Margin 6.30
Profit Margin 2.30

Portfolios with ACOR

Latest ACOR Headlines from TheStreet

More Financial News for ACOR

Press Releases for ACOR

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter